Tag Archives: Alzheimer’s Disease Neuroimaging Initiative (ADNI) Cohort

Biomarker Assessments in Alzheimer’s Disease Clinical Trials (Quintiles / Frontiers in Aging Neuroscience)

Summary Accurate and sensitive tools are required for the early detection / diagnosis of Alzheimer’s Disease, particularly to assist research. Alzheimer’s Disease clinical trials make increasing use of biomarkers, particularly neuroimaging markers and cerebrospinal fluid (CSF) biomarkers obtained via invasive … Continue reading

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Quick Insights | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Rates of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia (Dementia and Geriatric Cognitive Disorders Extra)

Summary This systematic review examines and summarises published estimates for the rate(s) of conversion from mild cognitive impairment or amnestic mild cognitive impairment to Alzheimer’s Disease / dementia. Wide variations in conversion rates are observed. Full Text Link Reference Ward, … Continue reading

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Patient Care Pathway, Quick Insights, Statistics, Systematic Reviews | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment